The renal and cardiovascular effects of SGLT2 inhibition in combination with loop diuretics in patients with type 2 diabetes and chronic heart failure (RECEDE-CHF) trial
Event: ESC Congress 2020
Topic: Treatment
Session: Novel Pharmacotherapies and Surgical Procedures for Heart Failure: How To Succeed?
ESC 365 is supported by
